Core proposition
Motor and cognitive rehabilitation supported by virtual reality
An Apple-tier presentation of a medical device designed to increase engagement, personalize therapy, and simplify clinical workflow.
What it is
NIRVANA is a virtual reality-based medical device specifically designed to support motor and cognitive rehabilitation in patients with neuromotor disorders.

How it works
Immersive scenarios are projected onto wall or floor surfaces, where patients interact with sensory stimuli while real-time audiovisual biofeedback supports a highly personalized rehabilitation journey.

Why choose it
It makes rehabilitation more effective by engaging the patient in a stimulating experience that motivates them to follow the personalized program and actively perform each task.

Trusted by leading institutions





Immersive experience and total freedom of movement
NIRVANA creates a complete sensory room for neuromotor rehabilitation, giving patients a motivating environment while preserving total freedom of movement.

Highlights and plus
Motor Therapy, Cognitive Therapy, easy-to-read reports, cloud database, web-based interface, customizable clinical exercises, multi-user platform, and GDPR compliance.
Why choose our system
It stimulates proactivity, enables complete freedom of movement, validates clinical exercises, supports flexible therapeutic spaces, adds body tracking, and improves floor projection with auxiliary video support.
NIRVANA in the world
Read the success stories of NIRVANA users and the extraordinary results they have achieved.
Fondazione TOG
A multidisciplinary, state-of-the-art rehabilitation foundation.
Brain Cognitiva
Digital technology for motor and cognitive rehabilitation of neurological patients.
SER Gait Analysis Lab
A non-profit organization providing equal opportunities to people affected by neuromuscular diseases.
Request information on NIRVANA
Contact the team to explore the right configuration for your clinical workflow and therapeutic environment.



Reviews
There are no reviews yet.